Shingrix Vaccine is a recombinant, non-live vaccine indicated for the prevention of shingles (herpes zoster) in adults. It helps stimulate the immune system to reduce the risk of shingles and its associated complications, including postherpetic neuralgia.

Key Features:

• Recombinant, non-live vaccine for shingles prevention in adults.
• Each 0.5ml dose contains 50mcg of active antigen.
• Helps prevent herpes zoster and associated complications such as nerve pain.
• Administered intramuscularly in a two-dose schedule.
• Suitable for adults 50 years and older or as advised by a healthcare professional.
• Provides strong and long-lasting immune response.

Recommended Usage:
Administer two 0.5ml doses intramuscularly, 2–6 months apart, as directed by a healthcare provider. Store refrigerated at 2–8°C. Do not freeze. Use under the supervision of a qualified healthcare professional.